Skip to main content
Premium Trial:

Request an Annual Quote

Third Wave CEO Bought 5,000 Shares After Stock Fell

NEW YORK, March 17 (GenomeWeb News) - John Puisis, CEO of Third Wave Technologies, purchased 5,000 of his company's shares on March 15 at the low point of a stock-price slide precipitated by disappointing fourth quarter earnings, GenomeWeb News has learned.


Third Wave's share price reached $4.53 when Puisis made the recent purchase. John Nies, a Third Wave director, purchased 5,000 shares on March 11 at $4.77. The shares, which have more than regained the ground they lost since the decline, were up 5.34 percent, or $.26, at $5.11 in late-afternoon trading today. However, they are still short of the stock's 52-week high of $9.08.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more